Jump to content

Estradiol hemisuccinate/progesterone

From Wikipedia, the free encyclopedia
(Redirected from EHS/P4)
Estradiol hemisuccinate /
progesterone
Combination of
Estradiol hemisuccinateEstrogen
ProgesteroneProgestogen
Clinical data
Trade namesHosterona
Other namesEHS/P4
Routes of
administration
Intramuscular injection

Estradiol hemisuccinate/progesterone (EHS/P4), sold under the brand name Hosterona, is an injectable combination medication of estradiol hemisuccinate (EHS), an estrogen, and progesterone (P4), a progestogen, which is used to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation).[1][2][3][4][5] It is provided in the form of ampoules containing 20 mg/2 mL EHS and 100 mg/2 mL P4 and is administered by intramuscular injection.[3][4][5] The medication is available in Argentina and Paraguay.[1][2][3]

See also

[edit]

References

[edit]
  1. ^ a b "Hosterona". Drugs.com. Retrieved 2019-04-12.
  2. ^ a b Sweetman SC, ed. (2009). "Sex hormones and their modulators". Martindale: The Complete Drug Reference (36th ed.). London: Pharmaceutical Press. pp. 2101, 2127. ISBN 978-0-85369-840-1. Estrone [...] Progesterone [...] Multi-ingredient: [...] Arg.: [...] Hosterona
  3. ^ a b c "What is HOSTERONA and what is it for?" [Qué es HOSTERONA y para qué sirve?]. MatchMyRx (in Spanish).
  4. ^ a b "Hosterona". Los Medicamentos. 23 November 2012.
  5. ^ a b "Hosterona". Vademecum Paraguay.